HomeNDC LookupRxCUI directory › RxCUI 1359126

Estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet — RxCUI 1359126

RxNorm drug concept · Semantic clinical drug
RxCUI 1359126 Semantic clinical drug · SCD ● Current RxNorm concept 17 FDA products 24 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1359126
Official nameEstradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped17
Package NDCs mapped24
Reported Medicaid activity (SDUD)14,082 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Norethindrone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Most norethindrone tablets — including brands like Camila, Errin, Emzahh, and Affodel — are progestin-only birth control pills taken daily to prevent pre...
  • Regular combination birth control pills contain two hormones — estrogen and progestin. Norethindrone is a progestin-only pill, sometimes called the 'mini-pill.' Because it has no e...
  • How is this different from regular birth control pills?
  • The most common thing people notice is irregular bleeding — spotting between periods, or changes in your cycle. Headache, breast tenderness, nausea, and dizziness are also reported...
📖 Read our full Norethindrone guide →

🕸️ Concept Web — How Estradiol 1 MG / norethindrone acetate 0.5 MG Or... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet RxCUI 1359126

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Estradiol 4083
    • Norethindrone 7514
    • Estradiol / norethindrone 214551
    • Norethindrone acetate 31983
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Estradiol / norethindrone Oral Tablet 372073
    • Estradiol / norethindrone acetate Oral Tablet 2645955
    • Estradiol / norethindrone Oral Product 1165172
    • Estradiol / norethindrone Pill 1165173
    • Estradiol / norethindrone acetate Oral Product 2660925
    • Estradiol / norethindrone acetate Pill 2660952
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Estradiol 1 MG 315881
    • Norethindrone acetate 0.5 MG 1251322
  4. Packs 7

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 21 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • {28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack GPCK · 1359127
  • Estradiol 1 MG SCDC · 315881
  • Norethindrone acetate 0.5 MG SCDC · 1251322
  • Estradiol / norethindrone Oral Tablet SCDF · 372073
  • Estradiol / norethindrone acetate Oral Tablet SCDFP · 2645955
  • Estradiol / norethindrone Oral Product SCDG · 1165172
  • Estradiol / norethindrone Pill SCDG · 1165173
  • Estradiol / norethindrone acetate Oral Product SCDGP · 2660925
  • Estradiol / norethindrone acetate Pill SCDGP · 2660952

📦 FDA Products & Package NDCs

17 products · 24 package NDCs
24 package NDCs map to RxCUI 1359126 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-5455-28 1 BLISTER PACK in 1 CARTON (0093-5455-28) / 28 TABLET, FILM... Mimvey Teva Pharmaceuticals USA, Inc. 2010-06-02
00093-5455-42 5 BLISTER PACK in 1 CARTON (0093-5455-42) / 28 TABLET, FILM... Mimvey Teva Pharmaceuticals USA, Inc. 2010-06-02
50090-8003-00 1 BLISTER PACK in 1 CARTON (50090-8003-0) / 28 TABLET, FILM... Estradiol / Norethindrone Acetate A-S Medication Solutions 2026-06-25
50742-0657-28 1 BLISTER PACK in 1 CARTON (50742-657-28) / 28 TABLET in 1... Estradiol and Norethindrone Acetate Ingenus Pharmaceuticals, LLC 2019-04-03
50742-0657-68 6 BLISTER PACK in 1 CARTON (50742-657-68) / 28 TABLET in 1... Estradiol and Norethindrone Acetate Ingenus Pharmaceuticals, LLC 2019-04-03
50742-0657-84 3 BLISTER PACK in 1 CARTON (50742-657-84) / 28 TABLET in 1... Estradiol and Norethindrone Acetate Ingenus Pharmaceuticals, LLC 2019-04-03
50742-0658-28 1 BLISTER PACK in 1 CARTON (50742-658-28) / 28 TABLET in 1... Estradiol and Norethindrone Acetate Ingenus Pharmaceuticals, LLC 2019-04-03
50742-0658-68 6 BLISTER PACK in 1 CARTON (50742-658-68) / 28 TABLET in 1... Estradiol and Norethindrone Acetate Ingenus Pharmaceuticals, LLC 2019-04-03
50742-0658-84 3 BLISTER PACK in 1 CARTON (50742-658-84) / 28 TABLET in 1... Estradiol and Norethindrone Acetate Ingenus Pharmaceuticals, LLC 2019-04-03
51991-0474-28 1 BLISTER PACK in 1 CARTON (51991-474-28) / 28 TABLET, FILM... Estradiol / Norethindrone Acetate Breckenridge Pharmaceutical, Inc. 2008-04-17
51991-0623-28 1 BLISTER PACK in 1 CARTON (51991-623-28) / 28 TABLET, FILM... Estradiol / Norethindrone Acetate Breckenridge Pharmaceutical, Inc. 2011-06-09
59651-0424-28 1 BLISTER PACK in 1 CARTON (59651-424-28) / 28 TABLET, FILM... Etyqa Aurobindo Pharma Limited 2023-06-30
59651-0424-87 1 POUCH in 1 CARTON (59651-424-87) / 1 BLISTER PACK in 1 PO... Etyqa Aurobindo Pharma Limited 2023-06-30
59651-0425-28 1 BLISTER PACK in 1 CARTON (59651-425-28) / 28 TABLET, FILM... Etyqa Aurobindo Pharma Limited 2023-06-30
59651-0425-87 1 POUCH in 1 CARTON (59651-425-87) / 1 BLISTER PACK in 1 PO... Etyqa Aurobindo Pharma Limited 2023-06-30
60846-0231-01 1 BLISTER PACK in 1 CARTON (60846-231-01) / 28 TABLET, FILM... Activella Amneal Pharmaceuticals LLC 2019-05-01
60846-0232-01 1 BLISTER PACK in 1 CARTON (60846-232-01) / 28 TABLET, FILM... Activella Amneal Pharmaceuticals LLC 2019-05-01
69238-1251-08 5 CARTON in 1 CELLO PACK (69238-1251-8) / 1 DIALPACK in 1 C... Lopreeza Amneal Pharmaceuticals NY LLC 2014-10-01
69238-1252-08 5 CARTON in 1 CELLO PACK (69238-1252-8) / 1 DIALPACK in 1 C... Lopreeza Amneal Pharmaceuticals NY LLC 2014-10-01
69238-1609-06 1 BLISTER PACK in 1 CARTON (69238-1609-6) / 28 TABLET, FILM... LOPREEZA Amneal Pharmaceuticals NY LLC 2019-01-07
69238-1610-06 1 BLISTER PACK in 1 CARTON (69238-1610-6) / 28 TABLET, FILM... LOPREEZA Amneal Pharmaceuticals NY LLC 2019-01-07
70700-0303-85 3 POUCH in 1 CARTON (70700-303-85) / 1 BLISTER PACK in 1 PO... ABIGALE LO Xiromed LLC 2025-01-29
70700-0330-85 3 POUCH in 1 CARTON (70700-330-85) / 1 BLISTER PACK in 1 PO... ABIGALE Xiromed LLC 2025-01-29
79929-0012-07 84 BLISTER PACK in 1 POUCH (79929-012-07) / 28 TABLET in 1... ESTRADIOL AND NORETHINDRONE ACETATE Naari Pte. Limited 2024-06-11
Observed labelers: Ingenus Pharmaceuticals, LLC (6) · Amneal Pharmaceuticals NY LLC (4) · Aurobindo Pharma Limited (4) · Amneal Pharmaceuticals LLC (2) · Breckenridge Pharmaceutical, Inc. (2) · Teva Pharmaceuticals USA, Inc. (2) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.